B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

CREB1

MOLECULAR TARGET

cAMP responsive element binding protein 1

NCBI Gene: 138543 compounds

CREB1 (cAMP responsive element binding protein 1) is targeted by 43 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting CREB1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1cycloheximide2.5612
2Disulfiram2.208
3Azacitidine1.956
4Azacitidine1.956
5Apigenin 5,7,4'-trihydroxy-flavone,1.614
6Levalbuterol1.614
7Adenosine Monophosphate Adenine nucleotide containing1.614
8Levalbuterol1.614
9Bortezomib1.614
10Clofarabine1.614
11Dactinomycin1.614
12Danazol1.614
13Emetine1.614
14Ethidium1.614
15Isopentenyladenosine N(6)-[delta(3)-isopentenyl]adenosine. Isopentenyl derivative of adenosine which is1.614
16Sulbactam1.614
17trequinsin hydrochloride1.614
18chrysin1.102
19Genistein1.102
20Quercetin1.102
21Testosterone1.102
22Ciclopirox1.102
23Cladribine1.102
24Clenbuterol1.102
25Corticosterone1.102
26Dasatinib1.102
27Daunorubicin1.102
28Dinoprostone1.102
29Epinephrine1.102
30Ethinyl Estradiol1.102
31Imatinib Mesylate1.102
32Isoproterenol Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on1.102
33Nisoldipine1.102
34Nocodazole Nocodazole is1.102
35Masoprocol1.102
36Norepinephrine Precursor of epinephrine that is secreted by1.102
37o-Phthalaldehyde1.102
38Oxyphenbutazone1.102
39pivampicillin1.102
40Potassium Dichromate Chromic acid (H2Cr2O7), dipotassium salt.1.102
41Salmeterol Xinafoate1.102
42Tilorone1.102
43Urea1.102

About CREB1 as a Drug Target

CREB1 (cAMP responsive element binding protein 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 43 compounds with documented CREB1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

CREB1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.